Sigma-Aldrich today said that it has entered into an agreement with Pfizer to sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterisation, ...
Sigma-Aldrich has announced that it has entered into an exclusive agreement with IsoSciences, LLC, to distribute isotopically labeled bioactive compounds and their metabolites through its Aldrich ...
Download image ST. LOUIS, March 15 /PRNewswire-FirstCall/ -- Sigma-Aldrich® (Nasdaq: SIAL) today announced that it has entered into an agreement with Pfizer under ...